Gene · 6716
Papers1,787
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,787
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sinomenine Hydrochloride Can Ameliorate Benign Prostatic Hyperplasia by Lowering the 5α-Reductase 2 Level and Regulating the Balance between the Proliferation and Apoptosis of Cells. | Molecules | 2023 | 36677863 | PubTator, text mining | PubMed |
| Pathogenicity of PKCγ Genetic Variants-Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer. | Genes (Basel) | 2023 | 36672978 | PubTator, text mining | PubMed |
| Age-Related Dysfunction in Proteostasis and Cellular Quality Control in the Development of Sarcopenia. | Cells | 2023 | 36672183 | PubTator, text mining | PubMed |
| Additional evidence for the role of chromosomal imbalances and SOX8, ZNRF3 and HHAT gene variants in early human testis development. | Reprod Biol Endocrinol | 2023 | 36631813 | PubTator, text mining | PubMed |
| Comprehensive molecular analysis identifies eight novel variants in XY females with disorders of sex development. | Mol Hum Reprod | 2023 | 36617173 | PubTator, text mining | PubMed |
| Changes in the clinical management of 5α-reductase type 2 and 17β-hydroxysteroid dehydrogenase type 3 deficiencies in France. | Endocr Connect | 2023 | 36606580 | PubTator, text mining | PubMed |
| Genetic variations predicting progression with docetaxel and novel androgen-receptor pathway inhibitors. | Cancer Sci | 2023 | 36602227 | PubTator, text mining | PubMed |
| Chemopreventive Effect of Cinnamon and Its Bioactive Compounds in a Rat Model of Premalignant Prostate Carcinogenesis. | Cancer Prev Res (Phila) | 2023 | 36517462 | PubTator, text mining | PubMed |
| Utility of genetic work-up for 46, XY patients with severe hypospadias. | J Pediatr Urol | 2023 | 36496321 | PubTator, text mining | PubMed |
| A Phase II Trial of Abiraterone With Dutasteride for Second-Generation Antiandrogen- and Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancer. | J Clin Pharmacol | 2023 | 36484758 | PubTator, text mining | PubMed |
| "Stromal cells in prostate cancer pathobiology: friends or foes?" | Br J Cancer | 2023 | 36482187 | PubTator, text mining | PubMed |
| Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate. | Eur J Clin Pharmacol | 2023 | 36378297 | PubTator, text mining | PubMed |
| "Genetic scissors" CRISPR/Cas9 genome editing cutting-edge biocarrier technology for bone and cartilage repair. | Bioact Mater | 2023 | 36263098 | PubTator, text mining | PubMed |
| Development and function of the fetal adrenal. | Rev Endocr Metab Disord | 2023 | 36255414 | PubTator, text mining | PubMed |
| Fertility potential in 5α-reductase type 2 deficient males. | J Pediatr Urol | 2023 | 36153242 | PubTator, text mining | PubMed |
| Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity. | Asian J Androl | 2023 | 35975362 | PubTator, text mining | PubMed |
| The association between single nucleotide polymorphisms and ovarian cancer risk: A systematic review and network meta-analysis. | Cancer Med | 2023 | 35637613 | PubTator, text mining | PubMed |
| Examining the Mechanisms of Huachansu Injection on Liver Cancer through Integrated Bioinformatics Analysis. | Recent Pat Anticancer Drug Discov | 2023 | 35546757 | PubTator, text mining | PubMed |
| Epididymis cell atlas in a patient with a sex development disorder and a novel NR5A1 gene mutation. | Asian J Androl | 2023 | 35546286 | PubTator, text mining | PubMed |
| A classification of genes involved in normal and delayed male puberty. | Asian J Androl | 2023 | 35532554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6716/papers?page=12